MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2017 International Congress

    Non-motor features of p.A53T α-synuclein mutation carriers compared to sporadic Parkinson’s disease in a PPMI cohort .

    M. Stamelou, C. Koros, A. Simitsi, I. Beratis, X. Geronicola Trapali, D. Papadimitriou, N. Papagiannakis, A. Prentakis, D. Kontaxopoulou, S. Fragkiadaki, R. Antonelou, S. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: To evaluate the prevalence of non-motor symptoms in p.A53T SNCA-related PD patients as compared to sporadic PD (sPD) patients. Background: p.A53T α-synuclein (SNCA) mutation…
  • 2017 International Congress

    The hardest symptoms that bother patients with Parkinson’s disease

    V. Vuletic (Rijeka, Croatia)

    Objective: In this study we want to see what are the hardest and the most troublesome symptoms perceived by patients with Parkinson’s disease (PD). Background:…
  • 2017 International Congress

    NonMotor and Motor symptoms in Idiopathic Parkinson´s Disease and Secondary parkinsonism The “Parkinsons Well-Being MapTM” – a useful instrument in Clinical praxis.

    Ö. Skogar, M. Nilsson, S. Morberg (Jönköping SWEDEN, Sweden)

    Objective: To evaluate self-reported frequency and amplitude of the spectra of motor (MS) and Non Motor Symptoms (NMS) presented in the “Parkinsons Well-Being MapTM ”…
  • 2017 International Congress

    Non-motor symptoms in Parkinsons’s disease patients treated with levodopa-carbidopa intestinal gel infusion- the follow up study

    A. Križnar, N. Zupančič Križnar, M. Kramberger, J. Bon, R. Rajnar, L. Ocepek, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: To follow up the effect of continuous levodopa-carbidopa intestinal gel infusion (LCIG) on motor and non-motor symptoms in advanced Parkinson’s disease (aPD). Background: Non-motor…
  • 2017 International Congress

    Substantial psychiatric symptoms, sleep disturbances and reduced quality of life in well-treated adult patients with GTP-cyclohydrolase deficient dopa-responsive dystonia

    A. Kuiper, E. Timmers, M. Smit, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: The aim of this study was to systematically investigate the prevalence of psychiatric disorders, sleep problems and health-related quality of life (HRQoL) in patients…
  • 2017 International Congress

    Profiling the Non Motor Symptoms burden in Parkinson’s disease patients in Nigeria

    T. Farombi, A. Ogunniyi (Ibadan, Nigeria)

    Objective: To determine the frequency of Non- motor symptoms (NMS) burden using the non-motor symptoms questionnaire (NMSQuest). Background: Over the years, motor manifestations were more associated with…
  • 2017 International Congress

    Self-rated burden grading of nonmotor symptoms identifies landmarks and subtypes of Parkinson’s disease: first report from a Moscow-Madrid-London collaboration

    N. Titova, S. Cankaya, F. Spinnato, E. Katunina, P. Martinez-Martin, M. Qamar, K.R. Chaudhuri (Moscow, Russian Federation)

    Objective: To describe clinical and imaging biomarkers of nonmotor symptoms burden (NMSB) as defined by NMS questionnaire (NMSQ) scores in a prospective international cohort study…
  • 2017 International Congress

    Does the side of onset affect motor and non-motor symptoms in Parkinson’s disease?

    J. Silva, A. D'Abreu (Campinas, Brazil)

    Objective: To assess the association between motor and non-motor symptoms of Parkinson’s Disease (PD) and side of onset considering hand dominance. Background: PD motor symptoms…
  • 2017 International Congress

    Impulse control disorder and associated clinical factors in drug-naïve Parkinson’s disease.

    D. Gupta, M. Marano, S. Fahn (New York, NY, USA)

    Objective: To investigate various clinical factors associated with Impulse Control Disorders (ICD) in Parkinson's disease (PD) patients who have never been exposed to Dopamine Replacement…
  • 2017 International Congress

    Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life, Non-motor and Motor Symptoms

    H. Dafsari, J. Petry-Schmelzer, M. Strack, L. Stalinski, V. Visser-Vandewalle, A. Rizos, M. Silverdale, K. Ashkan, M. Samuel, J. Evans, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To study the long-term effects of bilateral subthalamic deep brain stimulation (STN-DBS) on Quality of Life (QoL), motor, non-motor symptoms (NMS) in patients with…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 63
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley